News Focus
News Focus
Replies to #86247 on Biotech Values
icon url

dewophile

11/13/09 5:44 PM

#86248 RE: Biowatch #86247

good point - interferon is still the main reason most pts defer therapy. i think the notion that once telaprevir is available a huge bolus of pts will be eliminated is unlikely since it is still a tough tough regimen even at 12+12.